NCT02768948View on ClinicalTrials.gov

Telmisartan Promotes the Differentiation of Monocytes Into Macrophages M2 in Diabetic Nephropathy?

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 5, 2017

Primary Completion Date

September 11, 2019

Study Completion Date

July 11, 2020

Conditions
Diabetic Nephropathy
Interventions
DRUG

telmisartan during 6 months

telmisartan during 6 months

DRUG

Losartan during 6 months

Losartan during 6 months

PROCEDURE

blood sample

blood sample

Trial Locations (1)

06000

CHU de Nice, Nice

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER

NCT02768948 - Telmisartan Promotes the Differentiation of Monocytes Into Macrophages M2 in Diabetic Nephropathy? | Biotech Hunter | Biotech Hunter